Douglas Ross

Douglas Ross

Plus aucun poste en cours

Fortune : 34 299 $ au 31/03/2024

64 ans
Health Services
Health Technology
Consumer Services

Profil

Douglas T.
Ross
was the founder of Applied Genomics, Inc. founded in 2000, where he held the title of Chief Scientific Officer.
He worked as Chief Scientific Officer at Clarient, Inc. from 2009 to 2012, at CardioDx, Inc., and at Life Technologies Corp.
from 2012 to 2014.
He also served as Chief Resident at The University of California, San Francisco.
He was Chief Scientific Officer at OncoCyte Corp.
from 2020 to 2022.
Dr. Ross received his undergraduate and doctorate degrees from the University of Washington.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
21/12/2022 11 706 ( 0,14% ) 34 299 $ 31/03/2024

Anciens postes connus de Douglas Ross

SociétésPosteFin
ONCOCYTE CORPORATION Chief Tech/Sci/R&D Officer 16/12/2022
Chief Tech/Sci/R&D Officer 01/04/2014
Chief Tech/Sci/R&D Officer -
The University of California, San Francisco Corporate Officer/Principal -
CARDIODX INC Chief Tech/Sci/R&D Officer -
Voir l'expérience en détail de Douglas Ross

Formation de Douglas Ross

University of Washington Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Douglas Ross

Relations

66

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
ONCOCYTE CORPORATION

Health Technology

Entreprise privées4

Health Services

Health Services

Health Technology

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Douglas Ross